BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  AdaptHealth Corp. Announces Third Quarter 2022 Results and Updates 2022 Outlook

  AdaptHealth Corp. announced today financial results for the third quarter ended September 30, 2022.

  November 8, 2022

   · 

  17 min read
• Pharm Country

  Arbutus to Present at Jefferies London Healthcare Conference

  Arbutus Biopharma Corporation today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 11:30 am GMT / 6:30 am EDT.

  November 8, 2022

   · 

  1 min read
• Business

  Sensei Biotherapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights

  Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today reported financial results for the third quarter ended September 30, 2022 and provided recent business updates.

  November 8, 2022

   · 

  9 min read
• Genetown

  Repligen Corporation to Present at Upcoming November 2022 Investor Conferences

  Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will present at two upcoming investor conferences.

  November 8, 2022

   · 

  1 min read
• Business

  Korro Bio Expands Leadership Team with Key Appointments

  Korro Bio, Inc today announced the appointment of Venkat Krishnamurthy, Ph.D., as Senior Vice President, Head of Platform and Stephanie Engels as Senior Vice President, Head of People and Culture.

  November 8, 2022

   · 

  4 min read
• Business

  Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

  Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for the three and nine months ended October 1, 2022.

  November 8, 2022

   · 

  34 min read
• Biotech Beach

  Cidara Therapeutics to Present at the Stifel Healthcare Conference

  Cidara Therapeutics, Inc. announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will present at the Stifel Healthcare Conference.

  November 8, 2022

   · 

  1 min read
• Genetown

  Mersana Therapeutics to Present at 2022 Jefferies London Healthcare Conference

  Mersana Therapeutics, Inc. announced that members of management will present at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022, at 3:50 p.m. GMT.

  November 8, 2022

   · 

  1 min read
• Biotech Beach

  Daré Bioscience to Present at the Stifel 2022 Healthcare Conference

  Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will present at the Stifel 2022 Healthcare Conference, being held November 15-16, 2022 in New York, NY.

  November 8, 2022

   · 

  2 min read
• Business

  MannKind Corporation Reports 2022 Third Quarter Financial Results

  MannKind Corporation reported financial results for the third quarter and nine months ended September 30, 2022.

  November 8, 2022

   · 

  12 min read